Ningbo Ebitda from 2010 to 2024

300439 Stock   11.43  0.05  0.44%   
Ningbo MedicalSystem's EBITDA is decreasing over the years with stable fluctuation. EBITDA is expected to dwindle to about 408.1 M. From 2010 to 2024 Ningbo MedicalSystem EBITDA quarterly data regression line had arithmetic mean of  434,897,550 and significance of  0.56. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
495.2 M
Current Value
408.1 M
Quarterly Volatility
203.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ningbo MedicalSystem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ningbo MedicalSystem's main balance sheet or income statement drivers, such as Interest Expense of 10.1 M, Selling General Administrative of 307.3 M or Total Revenue of 1.8 B, as well as many indicators such as . Ningbo financial statements analysis is a perfect complement when working with Ningbo MedicalSystem Valuation or Volatility modules.
  
This module can also supplement various Ningbo MedicalSystem Technical models . Check out the analysis of Ningbo MedicalSystem Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ningbo Stock

Ningbo MedicalSystem financial ratios help investors to determine whether Ningbo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ningbo with respect to the benefits of owning Ningbo MedicalSystem security.